Literature DB >> 15287721

Disparity in allosteric interactions of monastrol with Eg5 in the presence of ADP and ATP: a difference FT-IR investigation.

Edward J Wojcik1, Nadine A Dalrymple, Shannon R Alford, Richard A Walker, Sunyoung Kim.   

Abstract

Eg5 is a kinesin-like motor protein required for mitotic progression in higher eukaryotes. It is thought to cross-link antiparallel microtubules, and provides a force required for the formation of a bipolar spindle. Monastrol causes the catastrophic collapse of the mitotic spindle through the allosteric inhibition of Eg5. Utilizing a truncated Eg5 protein, we employ difference infrared spectroscopy to probe structural changes that occur in the motor protein with monastrol in the presence of either ADP or ATP. Difference FT-IR spectra of Eg5-monastrol-nucleotide complexes demonstrate that there are triggered conformational changes corresponding to an interconversion of secondary structural elements in the motor upon interaction with nucleotides. Notably, conformational changes elicited in the presence of ADP are different from those in the presence of ATP. In Eg5-monastrol complexes, exchange of ADP is associated with a decrease in random structure and an increase in alpha-helical content. In contrast, formation of the Eg5-monastrol-ATP complex is associated with a decrease in alpha-helical content and a concomitant increase in beta-sheet content. One or more carboxylic acid residues in Eg5 undergo unique changes when ATP, but not ADP, interacts with the motor domain in the presence of monastrol. This first direct dissection of inhibitor-protein interactions, using these methods, demonstrates a clear disparity in the structural consequences of monastrol in the presence of ADP versus ATP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15287721     DOI: 10.1021/bi048982y

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Allosteric drug discrimination is coupled to mechanochemical changes in the kinesin-5 motor core.

Authors:  Elizabeth D Kim; Rebecca Buckley; Sarah Learman; Jessica Richard; Courtney Parke; David K Worthylake; Edward J Wojcik; Richard A Walker; Sunyoung Kim
Journal:  J Biol Chem       Date:  2010-03-18       Impact factor: 5.157

2.  ATP hydrolysis in Eg5 kinesin involves a catalytic two-water mechanism.

Authors:  Courtney L Parke; Edward J Wojcik; Sunyoung Kim; David K Worthylake
Journal:  J Biol Chem       Date:  2009-12-15       Impact factor: 5.157

3.  Real-time structural transitions are coupled to chemical steps in ATP hydrolysis by Eg5 kinesin.

Authors:  Bokkyoo Jun; Sunyoung Kim
Journal:  J Biol Chem       Date:  2010-02-12       Impact factor: 5.157

4.  Loop 5-directed compounds inhibit chimeric kinesin-5 motors: implications for conserved allosteric mechanisms.

Authors:  Liqiong Liu; Sreeja Parameswaran; Jing Liu; Sunyoung Kim; Edward J Wojcik
Journal:  J Biol Chem       Date:  2010-12-02       Impact factor: 5.157

5.  NSC 622124 inhibits human Eg5 and other kinesins via interaction with the conserved microtubule-binding site.

Authors:  Sarah S Learman; Catherine D Kim; Nathaniel S Stevens; Sunyoung Kim; Edward J Wojcik; Richard A Walker
Journal:  Biochemistry       Date:  2009-03-03       Impact factor: 3.162

6.  Small molecule screen for candidate antimalarials targeting Plasmodium Kinesin-5.

Authors:  Liqiong Liu; Jessica Richard; Sunyoung Kim; Edward J Wojcik
Journal:  J Biol Chem       Date:  2014-04-15       Impact factor: 5.157

7.  Allostery Wiring Map for Kinesin Energy Transduction and Its Evolution.

Authors:  Jessica Richard; Elizabeth D Kim; Hoang Nguyen; Catherine D Kim; Sunyoung Kim
Journal:  J Biol Chem       Date:  2016-08-08       Impact factor: 5.157

8.  Small molecule allosteric uncoupling of microtubule depolymerase activity from motility in human Kinesin-5 during mitotic spindle assembly.

Authors:  Catherine D Kim; Elizabeth D Kim; Liqiong Liu; Rebecca S Buckley; Sreeja Parameswaran; Sunyoung Kim; Edward J Wojcik
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.